Clindamycin Hydrochloride Capsule
Product Images NDC 65862-185

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Clindamycin Hydrochloride (NDC 65862-185). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (150 mg (100 Capsules Bottle))

This is a description of Clindamycin Hydrochloride capsules manufactured by Aurobindo Pharma USA, Inc. The capsules are only available by prescription and contain 150mg of clindamycin hydrochloride, an antibiotic used to treat infections caused by bacteria. The usual dosage is 150mg four times daily, and the capsules should be stored at room temperature between 20°C to 25°C. The packaging meets USP Controlled Room Temperature requirements and should be kept in a tightly sealed, child-resistant container. The capsules are distributed from the company's location at 279 Princeton-Hightstown Road, East Windsor, NJ 08520, and are made in India.*

FDA Label Image

Package Label-principal Display Panel (300 mg (100 Capsules Bottle))

FDA Label Image

Chemical Structure (Clindamycin Str)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.